(NASDAQ: NEPH) Nephros's forecast annual revenue growth rate of 12.55% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 14.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 21.48%.
Nephros's revenue in 2026 is $19,124,000.On average, 4 Wall Street analysts forecast NEPH's revenue for 2026 to be $233,687,153, with the lowest NEPH revenue forecast at $223,481,999, and the highest NEPH revenue forecast at $241,666,714.
In 2027, NEPH is forecast to generate $256,095,064 in revenue, with the lowest revenue forecast at $246,041,902 and the highest revenue forecast at $263,618,650.